News
Venture Challenge Fall 2023 open for applications!
Are you a researcher in the life sciences and are you looking to turn your research into a viable product or service that helps patients, physicians or other researchers?
Sirius Medical Announces Major Funding Round To Further Accelerate Sales Growth and New Product Development
Eindhoven, Netherlands – 21 March 2023 – Sirius Medical, the leader in surgical marker navigation, today announced the successful closing of a Series B Round 12 M€.
Prolira Announces FDA Clearance of the DeltaScan®
Prolira Announces FDA Clearance of the DeltaScan® Brain State Monitor for Detecting Acute Encephalopathy (Acute Brain Failure), a Condition Affecting Millions of Hospitalized Patients 60 and Old
Oxford Nanopore Technologies and Cyclomics begin developer testing on non-invasive method for accurate and fast detection of molecules associated with cancer
Research collaboration has resulted in new ‘liquid biopsy’ research workflow using nanopore sequencing to detect molecules that are associated with cancer, circulating in blood
Cyclomics announces completion of seed financing round
Venture Challenge alumnus Cyclomics has completed a financing round driven by a group of private investors too accelerate the development of innovate technologies in the field of cancer genetic testing.
Meet the teams of the Proefdiervrij Venture Challenge 2023
Today the special Proefdiervrij (animal-free) edition of the Venture Challenge has started. In this Venture Challenge four teams participate with innovations that have the potential to reduce or replace animal testing.
Movax Biopharma wins 35.000 AtlasInvest Entrepreneurship Grant
Start-ups that win an AtlasInvest Entrepreneurship Grant can use the money to set up their own lab or expand their business, for example.
Venture Challenge Alumnus of 2010 NTRC Therapeutics closes deal with Symeres and sells CRO division Oncolines B.V
Oncolines B.V., the CRO division of NTRC B.V. has been acquired by Symeres. NTRC Therapeutics participated in the Venture Challenge of 2010. The team consisted of Guido Zaman and Rogier Buijsman.
Venture Challenge Alumnus Autosciber closes 1,2 Million Euro Seed round
Venture Challenge Alumnus Autoscriber, an AI-based voice recognition software that captures and summarises consultations between healthcare professionals and patients, has closed its Seed round at €1.2M.
Protinhi Therapeutics successful in EIC Accelerator
Venture Challenge alumnus Prothinhi Therapeutics was one of the 11 Dutch companies that were successful in the latest EIC Accelerator round, together they raised €77mln.